News

Under the agreement all of the company’s outstanding shares of common stock (other than shares of common stock held by Eisai or its subsidiaries or by stockholders who

Cell Therapeutics (CTI) made an initial payment of $10 million to Biogen Idec in exchange for control of US marketing, sales, and development of Zevalin. Under the terms

Proton Beam therapy is a new and remarkable type of cancer treatment that minimizes the unnecessary irradiation to the normal tissue compared with conventional electron beam and x-ray

Varian is acquiring the privately held business for approximately $2 million in cash plus an additional amount based on achievement of specified milestones. Pan-Pacific Enterprises, which has approximately

The agreement also grants Top Care Korea exclusive rights to distribute Exalenz’s BreathID System in Korea. Top Care Korea plans to launch BreathID System in first half of

The company has also issued five-year warrants to purchase 1,206,273 additional shares of its common stock at an exercise price of $8.034 per share. The warrants were purchased

Under the new partnership, the center will operate under the new name, University Ambulatory Surgery Center that will continue to operate as a multi- specialty center offering orthopedics,

The modern facility and $2 million redesign investment accommodates nSpire Health’s growing staff, implementation of lean manufacturing on new manufacturing lines, respiratory core lab facilities, customer care and

The tentative approval relates to the use of Stavzor in the treatment of manic episodes associated with bipolar disorder, monotherapy and adjunctive therapy in multiple seizure types (including